During this process, CD8+ T cells interact with hepatocytes, leading to the transition of NASH to hepatocellular carcinoma via activation of the LightβR and NF-κB signaling pathway in hepatocytes [89]. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.